Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement
1 other identifier
interventional
64
0 countries
N/A
Brief Summary
The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for chest hair enhancement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2015
Shorter than P25 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2014
CompletedFirst Posted
Study publicly available on registry
November 5, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedDecember 2, 2014
November 1, 2014
7 months
November 2, 2014
November 29, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
The change of global photographic assessment after 20 weeks from baseline
baseline and 20 weeks
Secondary Outcomes (1)
The change in number of hairs after 20 weeks from baseline
baseline and 20 weeks
Other Outcomes (3)
The change of hair diameter after 20 weeks from baseline
baseline and 20 weeks
Number of participants with adverse events
baseline and 20 weeks
Patient satisfaction by self-assessment questionnaires
baseline and 20 weeks
Study Arms (2)
Minoxidil
EXPERIMENTAL3% Minoxidil lotion is applied twice daily to the chest.
Placebo
PLACEBO COMPARATORPlacebo lotion is applied twice daily to the chest.
Interventions
Eligibility Criteria
You may qualify if:
- healthy male
You may not qualify if:
- serious underlying diseases
- history of chest/ hair treatment before 6 months
- history of surgery or trauma on chest area.
- history of minoxidil allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Lee S, Tanglertsampan C, Tanchotikul M, Worapunpong N. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study. J Dermatol. 2014 Feb;41(2):149-52. doi: 10.1111/1346-8138.12275. Epub 2013 Nov 8.
PMID: 24471459RESULTSuwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012 Oct;39(10):865-6. doi: 10.1111/j.1346-8138.2012.01579.x. Epub 2012 May 17. No abstract available.
PMID: 22594928RESULTTanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai. 2012 Oct;95(10):1312-6.
PMID: 23193746RESULT
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assitant Professor
Study Record Dates
First Submitted
November 2, 2014
First Posted
November 5, 2014
Study Start
January 1, 2015
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
December 2, 2014
Record last verified: 2014-11